Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Long-Term Debt RepaymentsShares IssuedShares OutstandingShares Outstanding
Ratios

Tenax Therapeutics (TENX) Shares Outstanding (2016 - 2026)

Tenax Therapeutics' Shares Outstanding history spans 7 years, with the latest figure at $1.4 million for Q4 2017.

  • On a quarterly basis, Shares Outstanding changed 0.42% to $1.4 million in Q4 2017 year-over-year; TTM through Dec 2017 was $1.4 million, a 0.42% change, with the full-year FY2017 number at $1.4 million, changed 0.42% from a year prior.
  • Shares Outstanding hit $1.4 million in Q4 2017 for Tenax Therapeutics, down from $28.2 million in the prior quarter.
  • Over the last five years, Shares Outstanding for TENX hit a ceiling of $33.7 million in Q1 2013 and a floor of $987.0 in Q2 2013.
  • Historically, Shares Outstanding has averaged $19.2 million across 5 years, with a median of $28.1 million in 2014.
  • Biggest five-year swings in Shares Outstanding: crashed 90.14% in 2013 and later surged 1343.36% in 2014.
  • Tracing TENX's Shares Outstanding over 5 years: stood at $6.8 million in 2013, then soared by 312.65% to $28.1 million in 2014, then tumbled by 95.0% to $1.4 million in 2015, then grew by 0.0% to $1.4 million in 2016, then increased by 0.42% to $1.4 million in 2017.
  • Business Quant data shows Shares Outstanding for TENX at $1.4 million in Q4 2017, $28.2 million in Q3 2017, and $28.2 million in Q2 2017.